MicroRNA 429 Regulates Mucin Gene Expression and Secretion in Murine Model of Colitis

Area of Science:

• Molecular biology
• Gastroenterology
• Biomedical research

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression involved in human disease pathogenesis.
• Ulcerative colitis (UC) is a chronic inflammatory bowel disease with complex molecular underpinnings.
• Identifying specific miRNAs and their targets is crucial for understanding UC and developing novel therapies.

Purpose of the Study:

• To detect miRNAs associated with ulcerative colitis (UC).
• To identify target molecules of these miRNAs.
• To analyze miRNA-target gene correlations in colorectal cells and a mouse model of colitis.

Main Methods:

• miRNA microarray analysis and quantitative real-time PCR (RT-PCR) for miRNA identification and validation.
• mRNA microarray analysis and luciferase reporter assays to identify and confirm MIR429 target genes.
• Western blot, ELISA, and immunohistochemistry to assess protein expression levels.

Main Results:

• 37 differentially expressed miRNAs were identified in DSS-induced colitis.
• MIR429 was found to be down-regulated in colitis and targets 41 genes.
• MIR429 directly targets MARCKS, down-regulating its expression and subsequently affecting mucin secretion.

Conclusions:

• MIR429 modulates mucin secretion in colorectal cells and colitis tissues via MARCKS regulation.
• MIR429 represents a potential therapeutic candidate for anti-colitis strategies in human UC.